GSA Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

GSA Capital Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,670	Closed	-$250K	–	2103
2016 Q1	$250K	Buy	4,670 +1,353	+41%	+$99.9K	0.02%	1394
2015 Q4	$375K	Sell	3,317 -20,455	-86%	-$2.25M	0.02%	1337
2015 Q3	$2.8M	Buy	23,772 +15,806	+198%	+$2.06M	0.14%	139
2015 Q2	$617K	Buy	+7,966	New	+$522K	0.02%	1218
2015 Q1	–	Sell	-6,905	Closed	-$223K	–	2373
2014 Q4	$223K	Sell	6,905 -11,471	-62%	-$344K	0.02%	1418
2014 Q3	$450K	Buy	18,376 +6,400	+53%	+$130K	0.02%	1000
2014 Q2	$212K	Buy	+11,976	New	+$193K	0.01%	1597
2014 Q1	–	Sell	-10,918	Closed	-$183K	–	2051
2013 Q4	$183K	Buy	+10,918	New	+$151K	0.01%	1487

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

GSA Capital Partners's ANAC Position: Q2 2016 in Review

GSA Capital Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,670 shares — an estimated $250K sold.

GSA Capital Partners first reported a position in ANAC in Q4 2013 and held it in 8 quarters. The position peaked at $2.8M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

GSA Capital Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
GSA Capital Partners sold 4,670 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $250K.
GSA Capital Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 8 quarters.
GSA Capital Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $2.8M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.